Metronomic administration of pegylated liposomal-doxorubicin in extensively pre-treated metastatic breast cancer patients: A mono-institutional case-series report

This publication has 26 references indexed in Scilit:

• Metronomic Cyclophosphamide and Capecitabine Combined With Bevacizumab in Advanced Breast Cancer
  Journal of Clinical Oncology, 2008
• Single-agent treatment with pegylated liposomal doxorubicin for metastatic breast cancer
  Anti-Cancer Drugs, 2008
• Chemotherapy for Metastatic Breast Cancer
  Hematology/Oncology Clinics of North America, 2007
• Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer
  BMC Cancer, 2006
• Prolonged clinical benefit with metronomic chemotherapy in patients with metastatic breast cancer
  Anti-Cancer Drugs, 2006
• The anti-angiogenic basis of metronomic chemotherapy
  Nature Reviews Cancer, 2004
• Liposome-based drug delivery in breast cancer treatment
  Breast Cancer Research, 2002
• Redefining the Target: Chemotherapeutics as Antiangiogenics
  Journal of Clinical Oncology, 2001
• New Guidelines to Evaluate the Response to Treatment in Solid Tumors
  JNCI: Journal of the National Cancer Institute, 2000
• Doxorubicin Encapsulated in Liposomes Containing Surface‐Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS‐Related Kaposi's Sarcoma
  The Journal of Clinical Pharmacology, 1996